ICRM
LLY icon

Insight Capital Research & Management’s Eli Lilly LLY Stock Holding History

Insight Capital Research & Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-45,963
Closed -$3.87M – 107
2015
Q4 		$3.87M Sell
45,963
-949
-2% -$78.8K 1.13% 38
2015
Q3 		$3.93M Buy
+46,912
New +$3.96M 1.19% 38

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Insight Capital Research & Management's LLY Position: Q1 2016 in Review

Insight Capital Research & Management sold out of Eli Lilly (LLY) in Q1 2016, closing a stake of 45,963 shares — an estimated $3.87M sold.

Insight Capital Research & Management first reported a position in LLY in Q3 2015 and held it in 2 quarters. The position peaked at $3.93M in Q3 2015. 1,151 funds tracked by Wall St. Rank hold LLY as of Q1 2016.

  • Insight Capital Research & Management reported no remaining Eli Lilly position as of Q1 2016 after selling out during the quarter.
  • Insight Capital Research & Management sold 45,963 Eli Lilly shares in Q1 2016, an estimated $3.87M.
  • Insight Capital Research & Management first reported a position in Eli Lilly in Q3 2015 and held it in 2 quarters.
  • Insight Capital Research & Management's Eli Lilly position peaked at $3.93M in Q3 2015.
  • 1,151 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.

Based on Insight Capital Research & Management's 13F filing for Q1 2016, filed 10 May 2016.